PTAB Year in Review: New Designated Decisions and Procedures Impact AIA Trial Strategies
post-grant-review1
inter-partes-review
ex-parte-reexamination
While 2020 was an impactful year for everyone, the Patent Trial and Appeal Board (PTAB) designated numerous decisions and implemented procedural changes that affect AIA Trial Practice. These new developments include:
Join Brooks Kushman post-grant professionals Andrew Turner, John Rondini, and Reza Esfahani as they review these developments and discuss potential strategies to maximize the benefits from these changes while avoiding potential issues.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.